S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

ITRM Iterum Therapeutics PLC

1.7701

0.0201 (1.15%)

21 Dec 2024 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Iterum Therapeutics (NASDAQ:ITRM)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Iterum Therapeutics Charts.

Iterum Therapeutics (NASDAQ:ITRM)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Iterum Therapeutics Charts.

Iterum Therapeutics PLC News

Form 8-K - Current report
Wednesday 11 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Tuesday 10 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 22 November 2024 (1 month ago) • Edgar (US Regulatory)

Iterum Therapeutics Regains Full Nasdaq Compliance
Friday 22 November 2024 (1 month ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Iterum Therapeutics Reports Third Quarter 2024 Financial Results
Thursday 14 November 2024 (1 month ago) • GlobeNewswire Inc.

Iterum Therapeutics to Report Third Quarter 2024 Financial Results on November 14, 2024
Tuesday 12 November 2024 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Saturday 2 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Wednesday 30 October 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Monday 28 October 2024 (2 months ago) • Edgar (US Regulatory)

Iterum Therapeutics to Host Morning Conference Call on U.S. FDA Approval of ORLYNVAH™ (Oral Sulopenem) for the Treatment of Uncomplicated Urinary Tract Infections
Monday 28 October 2024 (2 months ago) • PR Newswire (US)

More Iterum Therapeutics PLC News Articles

Australia And New Zealan...

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions